Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Neurol ; 147(2): 221-8, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9344547

RESUMO

Activation of the endosomal-lysosomal system and altered expression of various lysosomal hydrolases have been implicated in several senescence-dependent neurodegenerative disorders and occurs, to a lesser extent, in the course of normal brain aging. The progressive accumulation of autofluorescent, peroxidase-positive astrocytic granules represents a highly consistent biomarker of aging in the vertebrate CNS. The sulfhydryl agent cysteamine greatly accelerates the accumulation of these glial inclusions in situ and in primary brain cell cultures. We previously determined that these glial inclusions are derived from abnormal mitochondria which undergo fusion with lysosomal elements in a complex autophagic process. In the present study, we demonstrate that cysteamine suppresses cathepsin B mRNA levels and immunoreactive protein in cultured astroglia, whereas cathepsin D mRNA and protein levels are significantly augmented by CSH exposure in these cells. Moreover, cathepsin D (but not cathepsin B) exhibits robust colocalization to the red autofluorescent inclusions. Concordant with our in vitro observations, cathepsin B immunoreactivity is prominent in the hypothalamic ventromedial nucleus which accumulates few autofluorescent glial inclusions during aging and is relatively inapparent in the heavily granulated hypothalamic arcuate nucleus. Conversely, cathepsin D is prominent in the aging arcuate nucleus where it colocalizes to the autofluorescent inclusions and exhibits scant immunoreactivity in the adjacent ventromedial nuclear complex. In senescent astroglia, oxidative stress may down-regulate the cathepsin B gene as part of a concerted cellular stress (heat shock) response. Glial cathepsin D, on the other hand, resists stress-related inhibition and may play an important role in disposing of oxidatively modified mitochondria in the aging and degenerating nervous system.


Assuntos
Envelhecimento/metabolismo , Núcleo Arqueado do Hipotálamo/efeitos dos fármacos , Astrócitos/efeitos dos fármacos , Catepsina B/biossíntese , Catepsina D/biossíntese , Cisteamina/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Corpos de Inclusão/efeitos dos fármacos , Lisossomos/enzimologia , Proteínas do Tecido Nervoso/biossíntese , Reagentes de Sulfidrila/farmacologia , Núcleo Hipotalâmico Ventromedial/efeitos dos fármacos , Envelhecimento/patologia , Animais , Núcleo Arqueado do Hipotálamo/enzimologia , Núcleo Arqueado do Hipotálamo/ultraestrutura , Astrócitos/ultraestrutura , Catepsina B/genética , Catepsina D/genética , Indução Enzimática/efeitos dos fármacos , Corpos de Inclusão/enzimologia , Lisossomos/efeitos dos fármacos , Fusão de Membrana , Microscopia de Fluorescência , Mitocôndrias/efeitos dos fármacos , Proteínas do Tecido Nervoso/genética , Estresse Oxidativo , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Sprague-Dawley , Núcleo Hipotalâmico Ventromedial/enzimologia , Núcleo Hipotalâmico Ventromedial/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...